IP Paralegal II/IP Docket Clerk at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, LegalIndustries

Requirements

  • IP docketing experience in global jurisdictions
  • Bachelor's degree with 4 years of legal work experience
  • Knowledgeable in Microsoft Office Suite applications, including Word, Excel, OneNote, SharePoint, Teams, and PowerPoint
  • Ability to quickly adapt to new software, services, and platforms
  • Excellent time management skills with ability to apply correct priority to workload
  • Strong ability to communicate effectively with attorneys, management, support staff, internal departments, outside counsel firms, and foreign agents across multiple office sites and time zones
  • Ability to apply critical thinking skillset to daily operations
  • Proactive in taking ownership of daily work and seeing it through to completion
  • Willingness to assist others with courtesy and cooperation
  • Demonstrates nimble response to change
  • Able to work with and contribute to an inclusive, accountable, high-performing team

Responsibilities

  • Organizing and maintaining records, deadlines, and documents, and communicating actions and deadlines to all stakeholders
  • Analyzing, interpreting, and docketing correspondence correctly per respective countries' laws and regulations
  • Creating specialty reports based on specific data requests
  • Providing ad-hoc training on the IP docketing database to global team members
  • Assisting the Docketing Manager with the development and implementation of new docketing policies and procedures to enhance user service while mitigating risk
  • Collaborating with team members to enhance procedures and develop best practices
  • Assisting with project management of file transfers, including managing incoming data quality from transferring-in portfolios and partnering with attorney and paralegal teams throughout the transfer process
  • Ensuring the accuracy and completeness of docketing deadlines from documents received from USPTO within Code of Federal Regulations requirements, clients, other Non-US government agencies, and Non-US associates
  • Regularly identifying and escalating data discrepancies and coordinating corrective action directly or in collaboration with the Docketing Manager
  • Providing backup coverage for the daily download of USPTO eOffice Actions as directed
  • Assisting with and/or leading project work, including verifying data related to acquired patent assets
  • Participating in a feedback-rich, psychologically safe culture that enables talent development
  • Collaborating with team members to innovate workflows and processes

Skills

IP docketing
global jurisdiction docketing
IPMS
Intellectual Property Management System
patent docket management
statutory deadlines
IP records management
specialty reports
docketing database training

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI